Epigenetic modifications: basic mechanisms and role in cardiovascular disease.
about
Epigenetics in heart failure phenotypesInsulin-like growth factors and their potential role in cardiac epigeneticsEpigenetic associations in relation to cardiovascular prevention and therapeuticsDNA modifications: function and applications in normal and disease StatesEpigenetic mechanisms underlying cardiac degeneration and regenerationEpigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular ComplicationsGenetics of coronary artery diseaseClinical applications of epigenetics in cardiovascular disease: the long road aheadO-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter?Epigenetic regulation of Keap1-Nrf2 signalingEpigenetic Regulation in Particulate Matter-Mediated Cardiopulmonary Toxicities: A Systems Biology PerspectiveMitochondrial health, the epigenome and healthspanComputational Analysis and Predictive Cheminformatics Modeling of Small Molecule Inhibitors of Epigenetic ModifiersDisturbance of cardiac gene expression and cardiomyocyte structure predisposes Mecp2-null mice to arrhythmiasGenetic epidemiology of titin-truncating variants in the etiology of dilated cardiomyopathy.Microfluidics for genome-wide studies involving next generation sequencing.Protein arginine hypomethylation in a mouse model of cystathionine β-synthase deficiency.Oligodeoxynucleotides Can Transiently Up- and Downregulate CHS Gene Expression in Flax by Changing DNA Methylation in a Sequence-Specific Manner.Epigenetic modifications: basic mechanisms and role in cardiovascular disease (2013 Grover Conference series).Molecular mechanisms of vascular dysfunction and cardiovascular biomarkers in type 2 diabetes.Notable epigenetic role of hyperhomocysteinemia in atherogenesis.Protein arginine methylation is more prone to inhibition by S-adenosylhomocysteine than DNA methylation in vascular endothelial cells.The association between progression of atherosclerosis and the methylated amino acids asymmetric dimethylarginine and trimethyllysine.Genome-wide identification of long noncoding RNAs in rat models of cardiovascular and renal diseaseThe genetic basis of peripheral arterial disease: current knowledge, challenges, and future directions.Epigenetic mechanisms of pulmonary hypertension.Homocysteine thiolactone and N-homocysteinylated protein induce pro-atherogenic changes in gene expression in human vascular endothelial cells.Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control studyThe role of epigenetics in spermatogenesis.Identification and Structure-Activity Relationship Studies of Small-Molecule Inhibitors of the Methyllysine Reader Protein Spindlin1.The role of redox signaling in epigenetics and cardiovascular disease.Selenistasis: epistatic effects of selenium on cardiovascular phenotype.SIRT1, p66(Shc), and Set7/9 in vascular hyperglycemic memory: bringing all the strands togetherThe Mechanobiology of AgingMethoxistasis: integrating the roles of homocysteine and folic acid in cardiovascular pathobiology.Genetics and epigenetics of arrhythmia and heart failure.Malondialdehyde mediates oxidized LDL-induced coronary toxicity through the Akt-FGF2 pathway via DNA methylation.In vitro analysis of factors influencing CYP1A2 expression as potential determinants of interindividual variation.Epigenetics and chromatin remodeling in adult cardiomyopathy.Recent advances in the bioanalysis of modified nucleotides in epigenetic studies.
P2860
Q26747565-505E6F38-175D-49B3-A7BB-A2C8981BAC62Q26750525-857392FC-2B63-4D33-A6DB-2EC087F9D99BQ26771428-BF4F43B9-F32E-4F61-9372-6FABE3B25AC0Q26829214-E230EEB8-6856-46DB-9441-DD1DF6053478Q26853220-2A807309-44C6-4D3F-8B87-E82323AA8131Q26859263-0A2D2329-977B-45F6-A0EA-89CEE258A720Q26866396-B8575DD0-868A-4AAF-8E58-48857DFCBD0EQ27008290-E56996DF-6D6A-41DC-97B7-45D91BBE5791Q27693206-042A67E7-4D1B-4D87-99A8-DE77C82F1808Q28084220-1654E332-E780-4DB0-AFFD-CFE5292DF012Q28391305-346CF789-9695-4DBD-84FF-33278E0CC30EQ28391740-332BBF7F-FAD7-419A-A35E-AB4CDBDA1BF5Q28554035-6F3F0DEF-AC3C-4631-9E6E-A3C6FB800AF6Q28648466-01AE1386-B47F-4041-B8FE-90DE07BE3846Q30234440-C5979D57-53E1-4D3F-8053-153C21D2AC9EQ30359014-62679592-B7C1-4B14-90F1-125C68873840Q33613244-FF1565B0-0B0F-47DD-9441-FCB01FADDD3BQ33679370-CBFFF20C-AE66-4C5B-AC9A-C435C8728565Q33806018-22439374-38EC-4ECE-B730-DC3B18B51BB8Q34099937-69260AEA-79ED-4918-B968-665823685D89Q34143826-6FF136A1-D8E7-414A-B56B-84DF6D59240CQ34586093-B59F20F2-C1DE-470E-AFE4-51C166C7D934Q34755672-4C026C2B-9876-42E9-9222-4661D4B71242Q35146760-BBA607A0-17C0-42BA-BBD3-00AC3567A2DDQ35540524-39D533EA-0A3F-4B35-B97A-663CDE2AA9C1Q35573935-96978C73-4746-4917-A2D9-454044AB3A6EQ35690674-BCBFF9B8-64A5-4892-A75A-936B2992E181Q35826444-B0D18BCF-FEF5-4684-80AA-9B52BD0EFDBFQ35993946-03B3D89C-4465-42E7-A759-7700208A283FQ36135192-0A0C2EB1-2F55-4070-B84B-E7F63B5B751CQ36761147-46D3E4EB-C0D5-484D-B840-AF126A983D42Q36792384-A7C6F822-803A-45FA-BD22-C5129099BB98Q36867464-84F479CB-CD54-4FC1-9DC0-E87E406DAC65Q36949552-F1FCED50-CBCD-45DA-B700-07A937CEC93FQ37177422-EE2D028D-9228-4400-B154-970BB4B8363BQ37267318-48347789-E376-4BF4-A439-9379F42680E4Q37596872-485122DC-14FE-4F80-AD84-CC11E4018B06Q37724295-25373094-DB4B-4444-8604-5A6B11A8CE10Q38118214-02DA5F60-D16B-42C3-844D-E3B9129088A6Q38167832-0597F80A-67DF-462E-8654-E9652E13A2B4
P2860
Epigenetic modifications: basic mechanisms and role in cardiovascular disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Epigenetic modifications: basic mechanisms and role in cardiovascular disease.
@ast
Epigenetic modifications: basic mechanisms and role in cardiovascular disease.
@en
Epigenetic modifications: basic mechanisms and role in cardiovascular disease.
@nl
type
label
Epigenetic modifications: basic mechanisms and role in cardiovascular disease.
@ast
Epigenetic modifications: basic mechanisms and role in cardiovascular disease.
@en
Epigenetic modifications: basic mechanisms and role in cardiovascular disease.
@nl
prefLabel
Epigenetic modifications: basic mechanisms and role in cardiovascular disease.
@ast
Epigenetic modifications: basic mechanisms and role in cardiovascular disease.
@en
Epigenetic modifications: basic mechanisms and role in cardiovascular disease.
@nl
P2860
P3181
P1433
P1476
Epigenetic modifications: basic mechanisms and role in cardiovascular disease
@en
P2093
Joseph Loscalzo
Rita Castro
P2860
P304
P3181
P356
10.1161/CIRCULATIONAHA.110.956839
P407
P577
2011-05-01T00:00:00Z